SBPH - Spring Bank Pharmaceuticals Inc.
Previous close
1.21
1.210 100.000%
Share volume: 86,743
Last Updated: Fri 20 Nov 2020 10:00:01 PM CET
Pharmaceuticals: Major:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
49%
Profitability
50%
Dept financing
50%
Liquidity
40%
Performance
50%
Sector
Health Technology
Industry
Pharmaceuticals: Major
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-20.48%
Return on assets
-14.35%
Return on sales
0%
Return on invested capital
4730.28%
Total debt ratio
30.58%
Debt ratio change over timeo
-0.9%
Current Ratio
9.73%
Quick Ratio
0%
Cash Position Ratio
4.45%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-24.46%
Return on assets
-14.22%
Return on sales
0%
Return on invested capital
23833.15%
Total debt ratio
37.98%
Debt ratio change over timeo
-0.81%
Current Ratio
6.45%
Quick Ratio
0%
Cash Position Ratio
3.12%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-28.17%
Return on assets
-17.27%
Return on sales
0%
Return on invested capital
2337.14%
Total debt ratio
25.28%
Debt ratio change over time
-0.4%
Current Ratio
5.11%
Quick Ratio
0%
Cash Position Ratio
1.66%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-109.25%
Return on assets
-102.15%
Return on sales
0%
Return on invested capital
476.45%
Total debt ratio
-90.39%
Debt ratio change over time
-0.9%
Current Ratio
-1.11%
Quick Ratio
0%
Cash Position Ratio
-0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | SBPH | FTSV | PRNB | RARX |
---|---|---|---|---|
Return on equity | -20.48% | -17.97% | -3.34% | -14.58% |
Return on assets | -14.35% | -15.67% | -1.22% | -13.27% |
Return on sales | 0% | 0% | 0% | 0% |
Return on invested capital | 4730.28% | 161.19% | -511.62% | 733.8% |
Profitability | 50% | 1% | 50% | 4% |
Total debt ratio | 30.58% | 14.54% | 27.48% | 9.46% |
Debt ratio change over time | -0.9% | -0.91% | -1.02% | -1% |
Dept financing | 50% | 12% | 22% | 8% |
Current Ratio | 6.45% | 11.14% | 16.04% | 20.26% |
Quick Ratio | 0% | 0% | 0% | 0% |
Cash Position Ratio | 3.12% | 5.36% | 4.16% | 19.67% |
Liquididy | 48% | 17% | 24% | 50% |
Short-term ratios | SBPH | FTSV | PRNB | RARX |
---|---|---|---|---|
Return on equity | -24.46% | -8.91% | -6.16% | -11.27% |
Return on assets | -14.22% | -8.75% | -5.93% | -10.9% |
Return on sales | 0% | 0% | 0% | 0% |
Return on invested capital | 23833.15% | 121.89% | -177.6% | 631.03% |
Profitability | 50% | 0% | 50% | 1% |
Total debt ratio | 37.98% | 10.61% | 9.15% | 6.33% |
Debt ratio change over time | -0.81% | -0.91% | -1.02% | -0.99% |
Dept financing | 50% | 7% | 6% | 4% |
Current Ratio | 6.45% | 11.14% | 16.04% | 20.26% |
Quick Ratio | 0% | 0% | 0% | 0% |
Cash Position Ratio | 3.12% | 5.36% | 4.16% | 19.67% |
Liquididy | 37% | 21% | 25% | 50% |